MSCA-1/TNAP selection of human jaw periosteal cells improves their mineralization capacity

Cellular Physiology and Biochemistry

Volumn 26, Issue 6, 2010, Pages 1073-1080

  Alexander, Dorothea ^a   Schäfer, Fabian ^a   Olbrich, Marcus ^a   Friedrich, Björn ^b   Bühring, Hans Jörg ^b   Hoffmann, Jürgen ^a   Reinert, Siegmar ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b Department of Internal Medicine IV   (Japan)

Author keywords

Jaw periosteal cells; LNGFR; Mineralization; MSCA 1 TNAP; Osteogenic capacity; Osteogenic marker

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; CELL MARKER; HUMAN MESENCHYMAL STEM CELL ANTIGEN 1; LOW AFFINITY NERVE GROWTH FACTOR RECEPTOR; MONOCLONAL ANTIBODY; NERVE GROWTH FACTOR RECEPTOR; STEM CELL ANTIGEN 1; TISSUE NON SPECIFIC ALKALINE PHOSPHATASE; UNCLASSIFIED DRUG;

ARTICLE; BONE CELL; BONE DEVELOPMENT; BONE MINERALIZATION; CELL DIFFERENTIATION; CELL FRACTIONATION; CELL ISOLATION; CELL POPULATION; CELL SELECTION; CONTROLLED STUDY; EXPERIMENTAL DESIGN; FLOW CYTOMETRY; HUMAN; HUMAN CELL; JAW; JAW PERIOSTEUM DERIVED CELL; MESENCHYMAL STEM CELL; OSTEOBLAST; PERIOSTEUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; WESTERN BLOTTING;

EID: 78651246951     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000323985     Document Type: Article

References (22)

1. Torroni A: Engineered bone grafts and bone flaps for maxillofacial defects: state of the art. J Oral Maxillofac Surg 2009;67:1121-1127.
2. Wang S, Zhang Z, Xia L, Zhao J, Sun X, Zhang X, Ye D, Uludag H, Jiang X: Systematic evaluation of a tissue-engineered bone for maxillary sinus augmentation in large animal canine model. Bone 2010;46:91-100.
3. Nakahara H, Bruder SP, Haynesworth SE, Holecek JJ, Baber MA, Goldberg VM, Caplan AI: Bone and cartilage formation in diffusion chambers by subcultured cells derived from the periosteum. Bone 1990;11:181-188.
4. Hutmacher DW, Sittinger M: Periosteal cells in bone tissue engineering. Tissue Eng 2003;9 Suppl 1:S45-S64.
5. De Bari C, Dell'Accio F, Luyten FP: Human periosteum-derived cells maintain phenotypic stability and chondrogenic potential throughout expansion regardless of donor age. Arthritis Rheum 2001;44:85-95.
6. De Bari C, Dell'Accio F, Vanlauwe J, Eyckmans J, Khan IM, Archer CW, Jones EA, McGonagle D, Mitsiadis TA, Pitzalis C, Luyten FP: Mesenchymal multipotency of adult human periosteal cells demonstrated by single-cell lineage analysis. Arthritis Rheum 2006;54:1209-1221.
7. D'Ippolito G, Schiller PC, Ricordi C, Roos BA, Howard GA: Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. J Bone Miner Res 1999;14:1115-1122.
8. Huibregtse BA, Johnstone B, Goldberg VM, Caplan AI: Effect of age and sampling site on the chondro-osteogenic potential of rabbit marrow-derived mesenchymal progenitor cells. J Orthop Res 2000;18:18-24.
9. Arnsdorf EJ, Jones LM, Carter DR, Jacobs CR: The periosteum as a cellular source for functional tissue engineering. Tissue Eng Part A 2009;15:2637-2642.
10. Alexander D, Schafer F, Munz A, Friedrich B, Klein C, Hoffmann J, Buhring HJ, Reinert S: LNGFR induction during osteogenesis of human jaw periosteum-derived cells. Cell Physiol Biochem 2009;24:283-290.
11. Buhring HJ, Battula VL, Treml S, Schewe B, Kanz L, Vogel W: Novel markers for the prospective isolation of human MSC. Ann N Y Acad Sci 2007;1106:262-271.
12. Battula VL, Bareiss PM, Treml S, Conrad S, Albert I, Hojak S, Abele H, Schewe B, Just L, Skutella T, Buhring HJ: Human placenta and bone marrow derived MSC cultured in serum-free, b-FGF-containing medium express cell surface frizzled-9 and SSEA-4 and give rise to multilineage differentiation. Differentiation 2007;75:279-291.
13. Buhring HJ, Treml S, Cerabona F, de Zwart P, Kanz L, Sobiesiak M: Phenotypic characterization of distinct human bone marrow-derived MSC subsets. Ann N Y Acad Sci 2009;1176:124-134.
14. Battula VL, Treml S, Bareiss PM, Gieseke F, Roelofs H, de Zwart P, Muller I, Schewe B, Skutella T, Fibbe WE, Kanz L, Buhring HJ: Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1. Haematologica 2009;94:173-184.
15. Alexander D, Hoffmann J, Munz A, Friedrich B, Geis-Gerstorfer J, Reinert S: Analysis of OPLA scaffolds for bone engineering constructs using human jaw periosteal cells. J Mater Sci Mater Med 2008;19:965-974.
16. Vogel W, Grunebach F, Messam CA, Kanz L, Brugger W, Buhring HJ: Heterogeneity among human bone marrow-derived mesenchymal stem cells and neural progenitor cells. Haematologica 2003;88:126-133.
17. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR: Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147.
18. Conget PA, Minguell JJ: Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J Cell Physiol 1999;181:67-73.
19. Minguell JJ, Erices A, Conget P: Mesenchymal stem cells. Exp Biol Med (Maywood) 2001;226:507-520.
20. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E: Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8:315-317.
21. Quirici N, Soligo D, Bossolasco P, Servida F, Lumini C, Deliliers GL: Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Exp Hematol 2002;30:783-791.
22. Sobiesiak M, Sivasubramaniyan K, Hermann C, Tan C, Orgel M, Treml S, Cerabona F, de Zwart P, Ochs U, Muller CA, Gargett CE, Kalbacher H, Buhring HJ: The mesenchymal stem cell antigen MSCA-1 is identical to tissue nonspecific alkaline phosphatase. Stem Cells Dev 2010;19:669-677.